Title:
HETEROCYCLIC COMPOUNDS AS SOS1 INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2022/262691
Kind Code:
A1
Abstract:
Provided herein are heterocyclic compounds shown in Formula (I) and their pharmaceutically acceptable salts thereof suitable for inhibiting or regulating the activity of SOS1. These compounds are useful for preventing and/or treating SOS1-mediated diseases, in particular cancers. Aslo provided are methods for preparing the mentioned compounds.
Inventors:
CHEN XIANGYANG (CN)
PANG YUCHENG (CN)
PANG YUCHENG (CN)
Application Number:
PCT/CN2022/098492
Publication Date:
December 22, 2022
Filing Date:
June 13, 2022
Export Citation:
Assignee:
BEIJING INNOCARE PHARMA TECH CO LTD (CN)
International Classes:
C07D403/12; A61K31/517; A61P35/00; C07D405/14; C07D409/04; C07D487/00; C07D487/02
Domestic Patent References:
| WO2022061348A1 | 2022-03-24 | |||
| WO2021074227A1 | 2021-04-22 | |||
| WO2018172250A1 | 2018-09-27 |
Foreign References:
| CN114380805A | 2022-04-22 | |||
| CN110167928A | 2019-08-23 | |||
| US6046206A | 2000-04-04 |
Attorney, Agent or Firm:
INTELIGHT IP LAW FIRM (CN)
Download PDF: